Skip to main content

Employees as research participants

August 25, 2016
Dr. Resnik has an M.A. and Ph.D. in philosophy from the University of North Carolina at Chapel Hill and J.D. from Concord University School of Law. He received his B.A. in philosophy from Davidson College. Dr. Resnik was an Associate and Full Professor of Medical Humanities at the Brody School...

CRISPR: The history, science and ethics of genetic modification

April 14, 2016
This event is co-sponsored by the Parr Center for Ethics and the UNC Center for Bioethics. For more information, see the Parr Center Events: CRISPR: The History, Science and Ethics of Genetic Modification.

Dignitary and other intangible harms in clinical research

February 17, 2016
Can research subjects be “wronged” even if not physically injured in a clinical trial? Thorny questions of how to account for such intangible harm currently challenge the courts, regulatory agencies, and IRBs. This presentation will consider the legal, ethical, and policy implications of noteworthy cases involving intangible harm, including alleged...

Paying research “volunteers”

February 17, 2016
Compensating research participants has been the subject of national debate for some time. In this presentation, I will review the four most common approaches to paying research participants and critically evaluate the impact of these schemes with relation to the risk:benefit ratio in research. I will also present the growing...

The ethics of clinical research during an epidemic

February 17, 2016
The 2014 Ebola epidemic in west Africa is the most severe and largest documented to date. It is also the first epidemic in which the use of experimental vaccines and specific treatments for Ebola was endorsed at an early stage. This talk will draw lessons from Ebola for conducting clinical...

Should we take the moral concerns of biobank donors seriously?

February 17, 2016
Biobanking is becoming an increasingly important component of genomic and medical research. President Obama’s Precision Medicine Initiative ― which proposes the collection of genetic and clinical data for upwards of 1 million Americans ― is just one example of this trend in medical science.  Because biobanks depend upon donations from a willing public,...

Join the Conquest

February 17, 2016
Clinical trial recruitment is in crisis. The public typically encounters clinical trial information in controversies or study-specific recruitment ads, which limits full understanding. To help address the national clinical trial recruitment crisis, researchers at UNC-CH used the social marketing approach to develop an evidence-based, online clinical research website and registry...

Should pediatricians “fire” vaccine-hesitant parents?

February 9, 2016
Visiting Ethics Scholar, John Lantos, MD, Director of Pediatric Bioethics, Professor of Pediatrics, University of Missouri-Kansas City.

Rationing is not a four letter word

February 9, 2016
Philip Rosoff, MD, Director Clinical Ethics Program, Professor of Pediatrics and of Medicine, Duke University.

The living and the dead

January 13, 2016
Susan E. Lederer is the Robert Turell Professor of the History of Medicine and Bioethics at the University of Wisconsin School of Medicine and Public Health, where she is the chair of the Department of Medical History and Bioethics. A historian of American medicine, she has written extensively on the...